E Fund Management Co. Ltd. cut its stake in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Free Report) by 9.8% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 11,197 shares of the biotechnology company’s stock after selling 1,215 shares during the period. E […] Read this story